Randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs adjuvant chemotherapy alone for localized soft tissue sarcoma (NACLESS, JCOG2102).
Yuki Funauchi(Japan Association for Development of Community Medicine), Toshifumi Ozaki(Okayama University), Toshiyuki Kunisada(Okayama University Hospital), Akihito Nagano(Gifu University), Kazuhiro Tanaka(Oita University), Satoshi Tsukushi(Aichi Cancer Center), Haruhiko Fukuda(National Cancer Center Hospital East), Koji Hiraoka, Yoshinao Oda(Kyushu University), Hiroaki Hiraga, Tsukasa Yonemoto, Tetsuya Sekita(Keio University), Ryunosuke Machida(Japan Clinical Cancer Research Organization), Yuta Sekino(Japan Clinical Cancer Research Organization), Akio Sakamoto, Akira Kawai(NTT (Japan)), Kazutaka Kikuta(Tochigi Cancer Center), Keisuke Ae(The Cancer Institute Hospital)
Cited by 0
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
|Journal of Thoracic Oncology|2011|656
Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201
|Journal of Thoracic and Cardiovascular Surgery|2013|348
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|344
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283